Evidence map›Paper›PMID 42543707›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Fluorination as a Molecular Design Parameter for Programming Peptide Nanocarriers.

Maurizio Iannuzzi, Holly Fiedler, Kilian Haoues, Suvrat Chowdhary, Hossein Batebi, Anil Kumar Sahoo, Andreas F Thünemann, Boris Schade, Elisa Quaas, Roland R Netz and 1 more

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maurizio IannuzziDepartment of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.ORCID https://orcid.org/0009-0002-8183-2150
Holly FiedlerDepartment of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Kilian HaouesDepartment of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Suvrat ChowdharyDepartment of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.
Hossein BatebiDepartment of Physics, Freie Universität Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-0714-9700
Anil Kumar SahooDepartment of Physics, Freie Universität Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0001-7769-4774
Andreas F ThünemannFederal Institute for Materials Research and Testing (BAM), Berlin, Germany.ORCID https://orcid.org/0000-0002-9883-6134
Boris SchadeCenter for Electron Microscopy Research (FZEM), Institute of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-9157-7897
Elisa QuaasInstitute of Chemistry and Biochemistry and Core Facility SupraFAB, Freie Universität Berlin, Berlin, Germany.
Roland R NetzDepartment of Physics, Freie Universität Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0003-0147-0162
Beate KokschDepartment of Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany.ORCID https://orcid.org/0000-0002-9747-0740

Funding

Deutsche Forschungsgemeinschaft (DFG) 387284271
6 · The paper itself

Abstract

Peptide-based nanocarriers offer unique opportunities for programmable self-assembly (SA), yet rational design strategies that couple structural control with biological function remain limited. In particular, fluoropeptides have been largely inaccessible as modular building blocks until the recent availability of enantiomerically pure fluorinated amino acids (FAAs) in gram-scale quantities, preventing their systematic use in functional nanomaterials. Here, we introduce fluorination as a quantitative molecular design parameter to program peptide SA, morphology, and biological performance. A homologous series of amphiphilic fluoropeptide-RGD conjugates was constructed in which the degree of side-chain fluorination is precisely controlled. We show that fluorination does not monotonically enhance assembly, but instead defines a narrow design window in which compact, non-amyloid fibrillar architectures emerge. Mechanistic insight from molecular dynamics (MD) simulations reveals how fluorine-induced modulation of hydrophobic interactions and hydration disrupts classical β-sheet packing. The optimized trifluorinated conjugate exhibits high drug-loading capacity, pH-triggered release, receptor-specific cellular uptake, and low cytotoxicity, while remaining enzymatically degradable. Together, these results establish fluorinated peptide segments as a previously inaccessible and programmable handle for the rational design of peptide-based nanocarriers.

Indexed as

Drug CarriersHalogenationNanoparticlesPeptidesHumansMolecular Dynamics SimulationDrug CarriersPeptidesbiocompatible materialsfluorinated amino acidsfluoropeptidessupramolecular nanocarrierstargeted drug delivery

Identifiers

PMID42543707
PMCPMC13653353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.